NR2F1 and neoplasm: Furthermore, the tumors produced by BHLHE41 and NR2F1 siRNA treated MCF-7 cells appeared to proliferate faster; the final tumor volume at day 12 was significantly larger for tumors produced by BHLHE41 and NR2F1 siRNA treated cells compared to those produced by control siRNA treated cells (Figure 3A–B).